Found 32 matching trials
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) NA Single-patient trial aiming to provide immunological consolidation followin...
Show More Learn More & Join Trial
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Show More Status
Active Not Recruiting
Location
Childrens National Medical Center
Learn More & Join Trial
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) PHASE1 The aim of this clinical trial is to evaluate the feasibility, safety and b...
Show More Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NA The goal of this prospective clinical study is to evaluate the safety and e...
Show More Location
The Catholic University of Korea Seoul St.Mary's Hospital
Learn More & Join Trial
Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT NA To evaluate the efficacy and safety of donor EBV-specific T lymphocytes (EB...
Show More Learn More & Join Trial
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation PHASE1 The purpose of this study is look at the safety of:
* Taking a specific co...
Show More Location
University of California, San Francisco
Learn More & Join Trial
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies PHASE1 The purpose of this phase I/II trial is to study the side effects and best ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity PHASE1 The primary purpose of this phase I/II study is to evaluate whether partial...
Show More Learn More & Join Trial